| Lastest Insider Transactions Of Trevi Therapeutics, Inc. ( TRVI ) | |||||||||
| Symbol | Company Name | Insider Name | Title | Date | Transation | Share | Price | Amount | File Date |
| TRVI | Trevi Therapeutics, Inc. | SCIASCIA THOMAS | Chief Scientific Officer | 2025-03-25 | Sell | 2,631 | 6.60 | 17,365 | 2025-03-26 16:30:14 |
| TRVI | Trevi Therapeutics, Inc. | SCIASCIA THOMAS | Chief Scientific Officer | 2025-03-25 | Option Exercise | 2,631 | 1.43 | 3,762 | 2025-03-26 16:30:14 |
| TRVI | Trevi Therapeutics, Inc. | GOOD JENNIFER L | President & CEO | 2025-03-21 | Sell | 5,263 | 6.58 | 34,625 | 2025-03-25 16:30:04 |
| TRVI | Trevi Therapeutics, Inc. | GOOD JENNIFER L | President & CEO | 2025-03-21 | Option Exercise | 5,263 | 1.43 | 7,526 | 2025-03-25 16:30:04 |
| TRVI | Trevi Therapeutics, Inc. | Simon Farrell | Chief Commercial Officer | 2025-03-10 | Sell | 81,313 | 6.75 | 548,878 | 2025-03-12 16:00:04 |
| TRVI | Trevi Therapeutics, Inc. | Simon Farrell | Chief Commercial Officer | 2025-03-10 | Option Exercise | 112,563 | 2.86 | 321,653 | 2025-03-12 16:00:04 |
| TRVI | Trevi Therapeutics, Inc. | Delfini Lisa | Chief Financial Officer | 2025-01-07 | Option Exercise | 6,000 | 0.51 | 3,066 | 2025-01-10 16:14:48 |
| TRVI | Trevi Therapeutics, Inc. | Galletta Christopher | See Remarks | 2024-12-13 | Option Exercise | 15,000 | 0.51 | 7,665 | 2024-12-17 16:30:03 |
| TRVI | Trevi Therapeutics, Inc. | SCIASCIA THOMAS | Chief Scientific Officer | 2024-08-14 | Sell | 31,505 | 2.77 | 87,228 | 2024-08-16 16:47:10 |
| TRVI | Trevi Therapeutics, Inc. | SCIASCIA THOMAS | Chief Scientific Officer | 2024-08-14 | Option Exercise | 31,505 | 1.43 | 45,052 | 2024-08-16 16:47:10 |
| TRVI | Trevi Therapeutics, Inc. | SCIASCIA THOMAS | Chief Scientific Officer | 2024-05-29 | Sell | 53,368 | 2.55 | 136,110 | 2024-05-31 16:07:36 |
| TRVI | Trevi Therapeutics, Inc. | SCIASCIA THOMAS | Chief Scientific Officer | 2024-05-29 | Option Exercise | 59,354 | 2.19 | 129,985 | 2024-05-31 16:07:36 |
| TRVI | Trevi Therapeutics, Inc. | Delfini Lisa | Chief Financial Officer | 2024-05-22 | Sell | 4,350 | 2.64 | 11,485 | 2024-05-24 16:12:05 |
| TRVI | Trevi Therapeutics, Inc. | Delfini Lisa | Chief Financial Officer | 2024-05-22 | Option Exercise | 16,043 | 0.51 | 8,198 | 2024-05-24 16:12:05 |
| TRVI | Trevi Therapeutics, Inc. | GOOD JENNIFER L | President & CEO | 2024-05-20 | Sell | 25,037 | 2.86 | 71,576 | 2024-05-22 16:30:37 |
| TRVI | Trevi Therapeutics, Inc. | GOOD JENNIFER L | President & CEO | 2024-05-20 | Option Exercise | 25,037 | 2.19 | 54,831 | 2024-05-22 16:30:37 |
| TRVI | Trevi Therapeutics, Inc. | GOOD JENNIFER L | President & CEO | 2024-05-10 | Sell | 4,578 | 2.90 | 13,276 | 2024-05-14 16:51:46 |
| TRVI | Trevi Therapeutics, Inc. | GOOD JENNIFER L | President & CEO | 2024-05-10 | Option Exercise | 4,578 | 2.19 | 10,026 | 2024-05-14 16:51:46 |
| TRVI | Trevi Therapeutics, Inc. | Delfini Lisa | Chief Financial Officer | 2023-10-11 | Sell | 785 | 2.02 | 1,586 | 2023-10-12 16:00:10 |
| TRVI | Trevi Therapeutics, Inc. | Delfini Lisa | Chief Financial Officer | 2023-10-11 | Option Exercise | 2,292 | 0.51 | 1,171 | 2023-10-12 16:00:10 |
| TRVI | Trevi Therapeutics, Inc. | Delfini Lisa | Chief Financial Officer | 2023-09-11 | Sell | 711 | 2.20 | 1,564 | 2023-09-13 16:06:00 |
| TRVI | Trevi Therapeutics, Inc. | Delfini Lisa | Chief Financial Officer | 2023-09-11 | Option Exercise | 2,291 | 0.51 | 1,171 | 2023-09-13 16:06:00 |
| TRVI | Trevi Therapeutics, Inc. | Delfini Lisa | Chief Financial Officer | 2023-08-11 | Sell | 682 | 2.36 | 1,610 | 2023-08-14 16:00:13 |
| TRVI | Trevi Therapeutics, Inc. | Delfini Lisa | Chief Financial Officer | 2023-08-11 | Option Exercise | 2,292 | 0.51 | 1,171 | 2023-08-14 16:00:13 |
| TRVI | Trevi Therapeutics, Inc. | Delfini Lisa | Chief Financial Officer | 2023-07-11 | Sell | 687 | 2.34 | 1,608 | 2023-07-12 16:29:03 |
| TRVI | Trevi Therapeutics, Inc. | Delfini Lisa | Chief Financial Officer | 2023-07-11 | Option Exercise | 2,292 | 0.51 | 1,171 | 2023-07-12 16:29:03 |
| TRVI | Trevi Therapeutics, Inc. | Simon Farrell | Chief Commercial Officer | 2023-06-20 | Option Exercise | 6,250 | 0.51 | 3,194 | 2023-06-21 16:00:12 |
| TRVI | Trevi Therapeutics, Inc. | Delfini Lisa | Chief Financial Officer | 2023-06-12 | Sell | 610 | 2.64 | 1,610 | 2023-06-14 16:28:46 |
| TRVI | Trevi Therapeutics, Inc. | Delfini Lisa | Chief Financial Officer | 2023-06-12 | Option Exercise | 2,291 | 0.51 | 1,171 | 2023-06-14 16:28:46 |
| TRVI | Trevi Therapeutics, Inc. | Delfini Lisa | Chief Financial Officer | 2023-05-11 | Sell | 562 | 2.89 | 1,624 | 2023-05-15 16:00:16 |
| TRVI | Trevi Therapeutics, Inc. | Delfini Lisa | Chief Financial Officer | 2023-05-11 | Option Exercise | 2,291 | 0.51 | 1,171 | 2023-05-15 16:00:16 |
| TRVI | Trevi Therapeutics, Inc. | Delfini Lisa | Chief Financial Officer | 2023-04-11 | Sell | 840 | 1.84 | 1,545 | 2023-04-12 17:02:13 |
| TRVI | Trevi Therapeutics, Inc. | Delfini Lisa | Chief Financial Officer | 2023-04-11 | Option Exercise | 2,292 | 0.51 | 1,171 | 2023-04-12 17:02:13 |
| TRVI | Trevi Therapeutics, Inc. | Delfini Lisa | Chief Financial Officer | 2023-03-13 | Sell | 892 | 1.75 | 1,564 | 2023-03-15 16:00:13 |
| TRVI | Trevi Therapeutics, Inc. | Delfini Lisa | Chief Financial Officer | 2023-03-13 | Option Exercise | 2,291 | 0.51 | 1,171 | 2023-03-15 16:00:13 |
| TRVI | Trevi Therapeutics, Inc. | Simon Farrell | Chief Commercial Officer | 2023-03-07 | Option Exercise | 18,750 | 0.51 | 9,581 | 2023-03-08 16:00:28 |
| TRVI | Trevi Therapeutics, Inc. | Delfini Lisa | Chief Financial Officer | 2023-02-13 | Sell | 8,474 | 2.45 | 20,761 | 2023-02-15 16:01:34 |
| TRVI | Trevi Therapeutics, Inc. | Delfini Lisa | Chief Financial Officer | 2023-02-13 | Option Exercise | 27,500 | 0.51 | 14,053 | 2023-02-15 16:01:34 |
